[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337791-105":59,"doc-detail-337791-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mrto4-enhances-glycolysis-to-facilitate-hcc-progression-by-inhibiting-aldob","MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB","","MRTO4 (MRT4 Homolog, ribosome maturation factor) is frequently upregulated in cancer cells, but its role in hepatocellular carcinoma (HCC) was unclear. This study used TCGA clinical data and expression analyses to assess associations with overall survival using Cox regression and built a prognostic nomogram combining MRTO4 with clinical variables. Experimental and bioinformatic results linked MRTO4 to energy metabolism reprogramming, showing accelerated glycolysis, increased proliferation and invasion, and reduced apoptosis via ALDOB inhibition. The findings suggest targeting MRTO4 as a therapeutic strategy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mrto4-enhances-glycolysis-to-facilitate-hcc-progression-by-inhibiting-aldob/337791/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mrto4-enhances-glycolysis-to-facilitate-hcc-progression-by-inhibiting-aldob/337791.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of the study on MRTO4 in HCC?","Question",{"text":113,"@type":114},"To clarify how MRTO4 affects HCC progression, including its prognostic value and its role in energy metabolism reprogramming.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was MRTO4 related to prognosis in HCC?",{"text":118,"@type":114},"MRTO4 was identified as an independent prognostic risk factor, and a nomogram combining MRTO4 expression with clinical pathological variables was constructed to predict outcomes.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism did the study propose for MRTO4-driven tumor behavior?",{"text":122,"@type":114},"MRTO4 was shown to promote glycolysis and facilitate HCC progression by inhibiting ALDOB, leading to increased proliferation and invasion and suppressed apoptosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337791,1790219343,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","DATABASE ANALYSIS  \ne-ISSN 1643-3750  \n© Med Sci Monit, 2024; 30: e944685 DOI: 10. 12659/MSM.944685  \nReceived: 2024.03.30  \nAccepted: 2024.04.30  \nAvailable online: 2024.05.15  \nPublished: 2024.05.23  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nABCD  \nCDE  \nCD  \nAEG  \nCorresponding Author: Financial support: Conflict of interest:  \nMRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB  \nYongyuan Zheng Yansong Huang Weibing Li Hongqiu Cheng  \nDepartment of Hepatology and Infectious Diseases, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, PR China  \nHongqiu Cheng, e-mail: [chenghongqiu@sohu.com](chenghongqiu@sohu.com)  \nThis work was funded by the Special Fund Project for Science and Technology of Guangdong Province (No. 2020035) None declared  \nBackground: MRT4 Homolog, Ribosome Maturation Factor (MRTO4) is often upregulated in cancer cells. However, its impact in hepatocellular carcinoma (HCC) is less well understood. Herein, we explored the prognostic and energy metabolism reprogramming role of MRTO4 in HCC.  \nMaterial/Methods: Clinical data were obtained from The Cancer Genome Atlas (TCGA), and the expression of MRTO4 in clinical samples was analyzed. The association between different variables and overall survival (OS) was studied, as well as their potential as independent prognostic factors, using Cox regression analysis. We constructed a nomogram including clinical pathological variables and MRTO4 expression to provide a predictive model for prognosis. Heatmaps, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed the relationship between energy metabolism pathways and MRTO4. We used classic molecular biology research methods, including RT-qPCR, Western blotting, CCK8, TUNEL, Clone formation, Transwell assay, ELISA, and immunohistochemistry, to study the role of MRTO4 in promoting the progression of HCC through glycolysis regulation.  \nResults: Our study showed that MRTO4 is an independent prognostic risk factor for HCC and that MRTO4 accelerates glycolysis of HCC cells, promotes proliferation and invasion, and suppresses apoptosis of HCC cells. The underlying mechanism involves MRTO4 promoting glycolysis and accelerating HCC by inhibiting ALDOB.  \nConclusions: Our study revealed a novel mechanism by which MRTO4 promotes glycolysis and accelerates HCC progression, and suggests that inhibiting MRTO4 could be a potential therapeutic strategy for HCC.  \nKeywords: Glycolysis • Liver Neoplasms • Cell Proliferation  \nAbbreviations: MRT4 – Homolog, Ribosome Maturation Factor (MRTO4); HCC – hepatocellular carcinoma;  \nTCGA – The Cancer Genome Atlas; AFP – a-fetoprotein; GEO – Gene Expression Omnibus;  \nHR – hazard ratio; PPI – protein–protein interactions; DAVID – The Database for Annotation, Visualization and Integrated Discovery; GO – gene ontology; KEGG – Kyoto Encyclopedia of Genes and Genomes; OS – overall survival; DEGs – differentially expressed genes; ssGSEA – single-sample gene set enrichment analysis; MF – molecular function; BP – biological pathways  \nFull-text PDF: [https://www.medscimonit.com/abstract/index/idArt/944685](https://www.medscimonit.com/abstract/index/idArt/944685)  \n5268  5  8  48  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne944685-1  \nIndexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System][ISI Journals Master List","cbCaidTVR6CrPEqF","https://ap.wps.com/l/cbCaidTVR6CrPEqF","pdf",10979231,24,"English","# Introduction\n## Clinical context and unmet needs in HCC\n## Metabolic reprogramming and glycolysis in cancer progression\n# Material/Methods\n## Data sources and survival analysis\n## Bioinformatics and functional validation assays","[{\"question\":\"What is the main purpose of the study on MRTO4 in HCC?\",\"answer\":\"To clarify how MRTO4 affects HCC progression, including its prognostic value and its role in energy metabolism reprogramming.\"},{\"question\":\"How was MRTO4 related to prognosis in HCC?\",\"answer\":\"MRTO4 was identified as an independent prognostic risk factor, and a nomogram combining MRTO4 expression with clinical pathological variables was constructed to predict outcomes.\"},{\"question\":\"What mechanism did the study propose for MRTO4-driven tumor behavior?\",\"answer\":\"MRTO4 was shown to promote glycolysis and facilitate HCC progression by inhibiting ALDOB, leading to increased proliferation and invasion and suppressed apoptosis.\"}]","MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB | PDF",1790020639,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/924967a69995f138dd59bf487c743e89.webp",983,1376,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76bfe3106a570da24a55ef78bf2c23ad.webp",982,1374,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8716a6af279f628c0e2fd2349fb9477.webp",981,1373,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/439ffc048721a5af1b45aa866358f50d.webp",980,1372]